CC
CLSA Capital Partners
Private EquityActiveThe alternative asset management arm of CLSA, Asia's leading independent brokerage and investment group
10
Investments
5
Exits
$3B
AUM
50.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for CLSA Capital Partners.
Investment Thesis & Strategy
CLSA Capital Partners, as a private equity firm, invests across various stages and industries in Asia, seeking to capitalize on opportunities within the region's diverse markets.
Investment Activity
Deals per year over the last 10 years
1
20094
20101
20110
20120
20130
20140
20151
20162
20171
2018Portfolio Companies
Selected investments from their portfolio of 10 companies
A
Asia Pacific Medical Group
Healthcare · Growth, 2018
G
Genting Hong Kong
Consumer · Growth, 2017
S
Sunac China Holdings
Real Estate · Growth, 2017
H
Huarong Investment
Fintech · Growth, 2016
C
China Agri-Products Exchange
Marketplaces · Growth, 2011
B
Beijing Capital Land
Real Estate · Growth, 2010
C
China Everbright International
Cleantech · Growth, 2010
C
China Resources Beer
Food & Beverage · Growth, 2010
C
China Modern Dairy
Food & Beverage · Growth, 2010
C
China Mengniu Dairy
Food & Beverage · Growth, 2009
Notable Exits
CompanyTypeYearValue / Acquirer
China Pacific InsuranceIPO2007—
Belle InternationalIPO2007—
Focus MediaIPO2005—
China Mengniu DairyIPO2004—
Shanghai Fudan MicroelectronicsIPO2000—
Frequently Asked Questions
CLSA Capital Partners focuses on Series B, Series C+ stage investments.